← Back
$ADVM All transactions

Adverum Biotechnologies, Inc.

D

$ Value

$0

Shares

8,000

Price

$0

Filed

Jun 20

Insider

Name

Ozden Rabia Gurses

Title

Chief Medical Officer

CIK

0001814883

Roles

Officer

Transaction Details

Transaction Date

2025-06-17

Code

D

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Effective March 21, 2024, the Issuer effected a reverse stock split (the "Reverse Split") whereby every ten shares of its issued and outstanding Common Stock were automatically combined into one share of Common Stock. In connection with the Reverse Split, each stock option to purchase ten shares of Common Stock was automatically combined into a stock option to purchase one share of Common Stock and the exercise prices of such options were multiplied by ten. | The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on March 17, 2022 and is fully vested. | The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 9, 2023 and is fully vested.

Filing Info

Accession No.

0001415889-25-017864

Form Type

4

Issuer CIK

0001501756

Ozden Rabia Gurses's History

Date Ticker Type Value
2025-12-09 ADVM U
2025-12-09 ADVM A $0
2025-12-09 ADVM U
2025-12-09 ADVM D
2025-12-09 ADVM D
2025-12-09 ADVM D
2025-12-09 ADVM D
2025-12-09 ADVM D
2025-06-17 ADVM D $0
2025-06-17 ADVM A $0

Other Insiders at ADVM (90d)

No other insider activity at this issuer in the last 90 days.